Everand Logo

Welcome to Everand!

  • STAT

    Opinion: The FDA’s plan to delay the new food label is a bad move for public health

    The FDA's proposal to give food companies until 2020 to use the new and improved Nutrition Facts label, which was ready to go in 2016, is a bad idea for…
    by Joan Salge Blake Oct 13, 2017 3 minutes
    Michelle Obama announces a makeover for food nutrition labels while speaking to the Building a Healthier Future Summit in Washington in May.

    I’m confused — and mad — about the Food and Drug Administration’s plan to delay the implementation of the much-needed new food label, the iconic rectangle of nutrition information that adorns food packages.

    Eighteen months ago, then-first lady Michelle Obama announced that she was “thrilled” that the FDA had finalized a new and improved label. It was going to be required on all packaged foods by July 2018. But now the FDA has proposed pushing back the required date to January 2020.

    I am scratching my head on

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
    Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
    Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
    STAT2 min read
    STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
    The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

    Related Books & Audiobooks